PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

While there’s no cure for multiple sclerosis (MS), there are many treatments ... According to one research review, mesenchymal stem cell (MSC) therapy may help reduce or prevent central nervous ...

Pheno Therapeutics has gained clinical trial authorisation (CTA) from the UK's MHRA for its small molecule therapeutic, ...

"But we would need large, randomized trials that compare hormone treatment to a placebo before we can know the true effects ...

This appears to slow or stop disease progression. For now, stem cell therapy is most likely to help people who have active inflammation or frequent relapses. Research does not suggest it can ...

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

Women are more likely to have such debilitating conditions as osteoporosis, migraines, Alzheimer disease, depression, ...

Carried into the hospital on his father’s back, the patient, a 24-year-old engineering student, walked out on his feet after ...

Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...

Living with multiple sclerosis was overwhelming, but their expertise and dedication in providing cell-based therapy have transformed my health and my future. I can now focus on my studies and dreams ...